Výsledky vyhledávání - "Janet Bodner"

An Integrated Approach To Teaching Assistant Training And Orientation

Autor: Ronald Kane, Clarisa Gonzalez-Lenahan, Michael Kerley, Jerome Paris, Janet Bodner, Ronald Rockland

Publikováno v: 2007 Annual Conference & Exposition Proceedings.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e656e07191bbdc9a367ff972863d1078
https://doi.org/10.18260/1-2--1678

Zobrazit plný text záznamu

Effect of valsartan on morbidity and mortality in heart failure patients with a history of hypertension: results from the valsartan heart failure trial

Autor: N.J. Holwerda, Janet Bodner, Lionel H. Opie, Nancy Feliciano

Publikováno v: Journal of the American College of Cardiology. 39

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0028126a6260fc372bcf7232a7b13e

Zobrazit plný text záznamu

Safety of Deferasirox (Exjade®) in Patients with Transfusion-Dependent Anemias and Iron Overload Who Achieve Serum Ferritin Levels <1000 Ng/Ml during Long-Term Treatment

Autor: Alan R. Cohen, John B. Porter, Antonio Piga, Lisa Rojkjaer, Janet Bodner, Maria Domenica Cappellini, John Ford

Publikováno v: Blood. 112:5423-5423

Background: Maintaining serum ferritin (SF) levels below 1000 ng/mL has been reported to predict longer survival and a reduced risk of complications (eg heart failure) in patients with thalassemia major. Experience with deferoxamine (Desferal®, DFO)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34ced2f013ccc58a81b462e3108dc10c
https://doi.org/10.1182/blood.v112.11.5423.5423

Zobrazit plný text záznamu

Design of an ongoing phase I/II open-label, dose-escalation trial using the oral chelator deferasirox to treat iron overload in HFE-Related hereditary hemochromatosis (HH)

Autor: Lisa Rojkjaer, Herbert L. Bonkovsky, Pradyumna D. Phatak, R. Weitzman, S. Bailey, Claus Niederau, Janet Bodner, Antonello Pietrangelo, Pierre Brissot

Publikováno v: Università degli studi di Modena e Reggio Emilia-IRIS
ResearcherID

HH is a genetic disorder commonly associated with homozygosity for the C282Y HFE mutation and characterized by progressive iron overload through increased intestinal absorption. Organ failure due to iron toxicity may develop. Iron removal by phleboto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::485e04793dd990c418073cd370abafc3
https://iris.unimore.it/handle/11380/605651

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání